Impact of Hypertension History and Blood Pressure at Presentation on Cardiac Remodeling and Mortality in Aortic Dissection

• Published in: Frontiers in cardiovascular medicine Vol. 8; p. 803283
• Main Authors: Oliveira, Matheus F R A, Rocha, Walter E M, Soares, Julia D, L'Armée, Victor M F S, Martins, Mayara P G, Rocha, Aloísio M, Feitosa, Audes D M, Lima, Ricardo C, Oliveira, Pedro P M, Silveira-Filho, Lindemberg M, Coelho-Filho, Otavio R, Matos-Souza, José R, Petrucci, Jr, Orlando, Sposito, Andrei C, Nadruz, Jr, Wilson
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 21.01.2022
• Subjects: aortic dissection; blood pressure; Cardiovascular Medicine; hypertension; left ventricular remodeling; mortality; mortality; blood pressure; left ventricular remodeling; aortic dissection; hypertension
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2021.803283

This study compared clinical, echocardiographic, and prognostic characteristics among patients with aortic dissection (AD) with (HypHist) and without (No-HypHist) hypertension history and evaluated the association of blood pressure (BP) at presentation with 1-year mortality, left ventricular (LV) remodeling and renal dysfunction. We investigated clinical and echocardiographic characteristics and 1-year mortality among 367 patients with AD (81% HypHist, 66% Type-A) from three Brazilian centers. Patients with No-HypHist were more likely to have Marfan syndrome, bicuspid aortic valve, to undergo surgical therapy, were less likely to have LV hypertrophy and concentricity, and had similar mortality compared with HypHist patients. Adjusted restricted cubic spline analysis showed that systolic BP (SBP) and diastolic BP (DBP) at presentation had a J-curve association with mortality among patients with No-HypHist, but did not associate with death among patients with HypHist ( for interaction = 0.001 for SBP and = 0.022 for DBP). Conversely, the association between SBP at presentation and mortality was influenced by previous use of antihypertensive medications in the HypHist group ( for interaction = 0.002). Results of multivariable logistic regression analysis comprising the whole sample showed direct associations of SBP and DBP at presentation with LV hypertrophy ( = 0.009) and LV concentricity ( = 0.015), respectively, and an inverse association between pulse pressure at presentation and estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m ( = 0.008). Combined information on BP at presentation, previous diagnosis of hypertension, and use of antihypertensive medications might be useful to predict mortality risk and to estimate extra-aortic end-organ damage among patients with AD.